These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8740233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [Abstract] [Full Text] [Related]

  • 3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system.
    Giometto B, Marchiori GC, Nicolao P, Scaravilli T, Lion A, Bardin PG, Tavolato B.
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):468-74. PubMed ID: 9460712
    [Abstract] [Full Text] [Related]

  • 7. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Idezuka J, Tsuji S.
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S.
    J Neurol Sci; 1998 Nov 26; 161(1):88-90. PubMed ID: 9879687
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
    Lennon VA, Kryzer TJ.
    Neurology; 1998 Jul 26; 51(1):327-9. PubMed ID: 9674845
    [No Abstract] [Full Text] [Related]

  • 12. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.
    Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C.
    J Neurol Sci; 1991 Nov 26; 106(1):82-7. PubMed ID: 1779243
    [Abstract] [Full Text] [Related]

  • 13. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB.
    N Engl J Med; 1990 Jun 28; 322(26):1844-51. PubMed ID: 2348838
    [Abstract] [Full Text] [Related]

  • 14. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
    Nardelli E, Currò-Dossi B, Rizzuto N, Graus F.
    Clin Neurol Neurosurg; 1995 Feb 28; 97(1):89-94. PubMed ID: 7540522
    [Abstract] [Full Text] [Related]

  • 15. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
    Matsushita H, Kodama S, Aoki Y, Tanaka K, Tanaka K, Saito N.
    Gynecol Obstet Invest; 1998 Feb 28; 45(2):140-3. PubMed ID: 9517809
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S.
    J Neurol Sci; 1999 Sep 15; 168(1):28-31. PubMed ID: 10500270
    [Abstract] [Full Text] [Related]

  • 17. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal.
    Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR.
    Ann Neurol; 1999 Jun 15; 45(6):805-9. PubMed ID: 10360776
    [Abstract] [Full Text] [Related]

  • 18. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C, Hamy A, De Ferron E, Paineau J, Visset J.
    J Gynecol Obstet Biol Reprod (Paris); 1996 Jun 15; 25(3):253-6. PubMed ID: 8767221
    [Abstract] [Full Text] [Related]

  • 19. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Nakajima T, Yamazaki M, Miyatake T, Tsuji S.
    J Neurol Neurosurg Psychiatry; 1995 Feb 15; 58(2):256-7. PubMed ID: 7876871
    [No Abstract] [Full Text] [Related]

  • 20. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A, Stourac P, Rusina R, Sejdová M, Velenská Z.
    Nervenarzt; 2002 Oct 15; 73(10):995-8. PubMed ID: 12376889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.